Aneuploidy-inducing gene knockdowns overlap with cancer mutations and identify Orp3 as a B-cell lymphoma suppressor

Area of Science:

• Genetics
• Cancer Biology
• Cell Biology

Background:

• Aneuploidy, an abnormal chromosome number, is linked to cancer initiation.
• Mutations in chromosome segregation genes are uncommon in tumors due to reduced cell fitness.
• Non-segregation genes, when knocked down, can induce aneuploidy, suggesting a role in cancer.

Purpose of the Study:

• To identify gene knockdowns that induce aneuploidy in human cancer cells.
• To investigate the role of these aneuploidy-inducing genes in cellular transformation and carcinogenesis.

Main Methods:

• Screening experiments to identify gene knockdowns causing aneuploidy in checkpoint-deficient human cancer cells.
• Computational analysis to identify overlap between identified genes and recurrent mutations in human cancers.
• In vitro studies on human fibroblasts and in vivo studies on mice (Orp3 knockout) to assess malignant transformation and tumor development.

Main Results:

• Identified several gene knockdowns that increase aneuploidy in human cancer cells, with overlap to recurrent cancer mutations.
• Knockdown of ORP3, GJB3, and RXFP1 enhanced malignant transformation of human fibroblasts.
• Orp3 knockout in mice led to lymphoid progenitor expansion, B-cell lymphoma development, deregulated phospholipid metabolism, and aberrant proliferation pathways.

Conclusions:

• Aneuploidy-inducing gene deficiencies contribute to cellular transformation and carcinogenesis.
• These deficiencies are associated with deregulation of key molecular processes including lipid metabolism, proliferation, and cell survival.
• The study implicates genes not directly involved in chromosome segregation as critical players in cancer development via aneuploidy.